Search form
Search
contact us
Navigation
home
boards
job ratings
cp wire
medtech news
pharmagather
catering
advertise
Legal Help
login/register
You are here
Home
»
companies
» Cardiovascular
Cardiovascular
Novartis pulls the plug on UK-based cardiovascular study
Novartis pulls the plug on UK-based cardiovascular study
Endpoints
Novartis
clinical trials
Leqvio
UK
Cardiovascular
Flag link:
Novartis says Leqvio launch will feature a 'modest initial ramp,' but blockbuster potential awaits
Novartis says Leqvio launch will feature a 'modest initial ramp,' but blockbuster potential awaits
Fierce Pharma
Novartis
Leqvio
drug launches
Cardiovascular
Flag link:
Big medtech convalesces after Covid-19
Big medtech convalesces after Covid-19
EP Vantage
Medtech
devices
COVID-19
pandemic
Orthopedics
Cardiovascular
diagnostics
Flag link:
This Is A Heart Drug That The World Doesn’t Need
This Is A Heart Drug That The World Doesn’t Need
Forbes
CETPi
Cardiovascular
Torcetrapib
Pfizer
Flag link:
Trulicity gets FDA nod for reducing CV risk in type 2 diabetes patients
Trulicity gets FDA nod for reducing CV risk in type 2 diabetes patients
Pharmaceutical Business Review
Eli Lilly
Trulicity
FDA
type 2 diabetes
Cardiovascular
Flag link:
With Vascepa nod in the bag, Amarin rolls CV risk campaign targeting passé prescription meds
With Vascepa nod in the bag, Amarin rolls CV risk campaign targeting passé prescription meds
Fierce Pharma
Amarin
Vascepa
Cardiovascular
television ads
DTC ads
Flag link:
Amarin eyes blockbuster Vascepa sales as FDA grants heart-helping label expansion
Amarin eyes blockbuster Vascepa sales as FDA grants heart-helping label expansion
Fierce Pharma
Amarin
Vascepa
FDA
Cardiovascular
Flag link:
AstraZeneca Taps Gatehouse Bio to Identify Potential Drug Targets
AstraZeneca Taps Gatehouse Bio to Identify Potential Drug Targets
Xconomy
AstraZeneca
Gatehouse Bio
R&D
Respiratory
Cardiovascular
sRNA
Flag link:
Viagra and Cialis: PDE-5 Inhibitors May Have Broader Applications in Cancer, Neurology and Cardiovascular Health
Viagra and Cialis: PDE-5 Inhibitors May Have Broader Applications in Cancer, Neurology and Cardiovascular Health
BioSpace
Viagra
Pfizer
Cialis
Eli Lilly
erectile dysfunction
cancer
Cardiovascular
drug repurposing
Flag link:
What’s AstraZeneca’s Largest Revenue Contributor?
What’s AstraZeneca’s Largest Revenue Contributor?
Yahoo/Market Realist
AstraZeneca
Cardiovascular
Flag link:
Sanofi Is Shuffling Its Exec Roster Amid Continued Struggles
Sanofi Is Shuffling Its Exec Roster Amid Continued Struggles
Fortune
Sanofi
diabetes
Cardiovascular
Flag link:
Medicines Co. sells off cardiovascular drugs to Italy's Chiesi
Medicines Co. sells off cardiovascular drugs to Italy's Chiesi
BioPharma Dive
Medicines Company
Cardiovascular
Italy
M&A
Chiesi
Flag link:
How Eli Lilly’s Cardiovascular Franchise Performed in 1Q16
How Eli Lilly’s Cardiovascular Franchise Performed in 1Q16
Yahoo/Market Realist
Eli Lilly
Cardiovascular
Flag link:
Cardiovascular Systems Reports Fiscal 2013 Second-Quarter Financial Results
Cardiovascular Systems Reports Fiscal 2013 Second-Quarter Financial Results
Yahoo/BusinessWire
Cardiovascular
earnings
devices
Flag link:
St. Jude Medical launches cardiovascular "GPS" technology
St. Jude Medical launches cardiovascular "GPS" technology
St. Jude Medical
Cardiovascular
technology
launch
Flag link:
Abiomed founder, cardiovascular pioneer, dies of cancer
Abiomed founder, cardiovascular pioneer, dies of cancer
Abiomed
Cardiovascular
cancer
innovation
Flag link:
Cardiovascular Systems Reports Fiscal 2012 Third-Quarter Financial Results
Cardiovascular Systems Reports Fiscal 2012 Third-Quarter Financial Results
Cardiovascular
earnings
Flag link:
Abbott and St. Jude Medical Broaden Alliance for Cardiovascular Products in the United States
Abbott and St. Jude Medical Broaden Alliance for Cardiovascular Products in the United States
Abbott Laboratories
St. Jude Medical
Cardiovascular
Flag link:
CardioInsight scores $7.5M for 3-D cardiovascular mapping
CardioInsight scores $7.5M for 3-D cardiovascular mapping
CardioInsight
funding
Cardiovascular
Flag link:
Four Cardiovascular Societies Release Criteria for TAVR Programs and Operators
Four Cardiovascular Societies Release Criteria for TAVR Programs and Operators
Cardiovascular
Flag link:
Pages
1
2
3
next ›
last »